Pulliam, Thomas L.
Goli, Pavithr
Awad, Dominik
Lin, Chenchu
Wilkenfeld, Sandi R.
Frigo, Daniel E. https://orcid.org/0000-0002-0713-471X
Article History
Accepted: 16 March 2022
First Online: 26 April 2022
Competing interests
: D.E.F. has received research funding from GTx, Inc., and has a familial relationship with Hummingbird Bioscience, Maia Biotechnology, Alms Therapeutics, Hinova Pharmaceuticals and Barricade Therapeutics. The other authors declare no competing interests. The funders had no role in the conceptualization or writing of the manuscript, or in the decision to publish this article.